Hipgnosis Songs Fund Limited (SONG.L)
| Previous close | 92.00 |
| Open | 91.50 |
| Bid | 91.80 x 0 |
| Ask | 91.90 x 0 |
| Day's range | 91.30 - 92.03 |
| 52-week range | 52.90 - 139.87 |
| Volume | |
| Avg. volume | 9,234,752 |
| Market cap | 1.111B |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.05 (7.27%) |
| Ex-dividend date | 28 Sept 2023 |
| 1y target est | N/A |
- The Telegraph
IMF chief quotes Churchill as she warns of global chaos
The head of the International Monetary Fund has urged countries to cut debt and slash red tape to revive growth as she warned the world was becoming more vulnerable to economic shocks.
- The Guardian
UK music investor Hipgnosis agrees £1.1bn takeover by Concord Chorus
Shares in Beyoncé and Neil Young song fund rise amid hopes uncertainty over its future could be over
- Reuters
Hipgnosis agrees sale to Concord in $1.4 billion music rights deal
(Reuters) -Nashville-based independent music company Concord has agreed to buy Britain's Hipgnosis Songs Fund for $1.4 billion, the companies said on Thursday, to gain rights to the catalogues of artists including Shakira and Neil Young. Hipgnosis, a music rights investment company founded by industry veteran and former CEO Merck Mercuriadis, launched a strategic review last year after a shareholder revolt led to a board overhaul, a portfolio revaluation, and a dispute with its investment adviser over a call option. Hipgnosis shares, which listed in London in 2018 and have fallen more than 45% from their 2021 peak, rose 31% to 92.5 pence ($1.15).
